Alzheimer's disease drug development pipeline: 2019

INTRODUCTION: Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. METHODS:...

Full description

Saved in:
Bibliographic Details
Published in:Alzheimers Dement (N Y)
Main Authors: Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Sabbagh, Marwan, Zhong, Kate
Format: Artigo
Language:Inglês
Published: Elsevier 2019
Subjects:
Featured Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617248/
https://ncbi.nlm.nih.gov/pubmed/31334330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.05.008
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items